Formoterol Dose Ranging Study (ACHIEVE Duaklir USA Phase IIb)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark H. Gotfried, MD
1112 East McDowell Road, Phoenix, AZ 85006, United States.
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Glendale, Arizona, United States
- Research Site
Phoenix, Arizona, United States
- Research Site
Tempe, Arizona, United States
- Research Site
Celebration, Florida, United States
- Research Site
Clearwater, Florida, United States
- Research Site
DeLand, Florida, United States
- Research Site
Orlando, Florida, United States
- Research Site
Lawrenceville, Georgia, United States
- Research Site
St Louis, Missouri, United States
- Research Site
Las Vegas, Nevada, United States
- Research Site
Charlotte, North Carolina, United States
- Research Site
Gastonia, North Carolina, United States
- Research Site
Medford, Oregon, United States
- Research Site
Portland, Oregon, United States
- Research Site
Easley, South Carolina, United States
- Research Site
Greenville, South Carolina, United States
- Research Site
Rock Hill, South Carolina, United States
- Research Site
Spartanburg, South Carolina, United States
- Research Site
Boerne, Texas, United States
- Research Site
Killeen, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2016
- Primary completion
- 7 Dec 2016
- Completion
- 7 Dec 2016
- Last update posted
- 7 Feb 2018
- Registered enrollment
- 132
- Registry id
- NCT02796651
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.